John P. Brancaccio - 09 Mar 2022 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Director
Signature
/s/ John Brancaccio
Issuer symbol
CRDF
Transactions as of
09 Mar 2022
Net transactions value
$0
Form type
4
Filing time
10 Mar 2022, 17:38:47 UTC
Previous filing
03 Dec 2021
Next filing
16 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Award $0 +26,800 +27% $0.000000 125,317 09 Mar 2022 Common Stock 26,800 $2.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.